BlackRock Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
BFA
BIT
BlackRock Investment Management's HAE Position: Q4 2016 in Review
BlackRock Investment Management increased its Haemonetics (HAE) stake by 19% in Q4 2016, buying an estimated $1.68M and bringing the position to 279,106 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #1046.
BlackRock Investment Management first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. 197 funds tracked by Wall St. Rank hold HAE as of Q4 2016.
- BlackRock Investment Management held 279,106 shares of Haemonetics worth $11.2M as of Q4 2016.
- BlackRock Investment Management bought 44,544 Haemonetics shares in Q4 2016, an estimated $1.68M.
- Haemonetics made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1046 holding.
- BlackRock Investment Management first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
- 197 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.